Crowdonomics
WatchlistPortfolio
Opyrus

Reg CF · Common Stock · Feb 2021

ClosedReached targetReg CFCommon Equity
via WeFunderView campaign
Raised
$251K / $250K max
100% of ceiling · target hit day 1
Investors
165
$1.5K avg
Post-money valuation
$4.3M
pre-money + amount raised

Raised over time

Cumulative raisedInvestors
$175K$88K$0
161810
Feb 2, 2021 · openedJul 30, 2021 · last reading
Target ($50K) hit — Feb 3, 2021, day 1Deadline Apr 15, 2021

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via WeFunder; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2018–FY2019 · hover for source
$602K
−$829K
FY2018
$216K
−$503K
FY2019
RevenueNet income
Metric
FY2018 reviewed*
FY2019 reviewed*
Income statement
Revenue
$601,525
$215,671
Cost of goods sold
$542,464
$175,505
Gross margin
10%
19%
Net income
-$828,704
-$502,549
Taxes paid
$13,829
$9,563
Balance sheet
Cash
$102,842
$23,290
Accounts receivable
$44,128
$61,915
Total assets
$3,012,714
$2,706,119
Short-term debt
$752,429
$791,793
Long-term debt
$2,275,026
$2,431,441
Total liabilities
$3,027,455
$3,223,234
Other
Headcount
—
4

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

Pre-money$4.1M ($3.2M early bird)
Post-money$4.3M
Price / share$0.70
Shares offered89,286

Perks

$3,240,511.68 pre-money valuation$100K+

Offering details

Target$50,000
Max$250,000
Min investment$100
OpenedFeb 2, 2021
DeadlineApr 15, 2021
ClosedJul 30, 2021
Days active178

Links & provenance

Campaign pageSEC filing
Source: Manual
0001670254-20-001178

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.